CSIMarket
 
Accuray Incorporated  (NASDAQ: ARAY)
 
Price: $0.2668 $0.00 -1.185%
Day's High: $0.27219998836517334 Week Perf: 2.62 %
Day's Low: $ 0.25 30 Day Perf: -4.71 %
Volume (M): 278,401 52 Wk High: $ 2.10
Volume (M$): $ 0 52 Wk Avg: $0.72
Open: $0.27 52 Wk Low: $0.22



 Market Capitalization (Millions $) 33
 Shares Outstanding (Millions) 123
 Employees 809
 Revenues (TTM) (Millions $) 401
 Net Income (TTM) (Millions $) -49
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) 6

Business Description


Accuray Incorporated is a global provider of innovative precision radiation medicine solutions. The company was founded in 1990 and is headquartered in Sunnyvale, California, USA. The company's mission is to develop and deliver advanced radiation therapies that help people live longer, healthier lives.

Accuray's flagship product is the CyberKnifee System, which is the world's first and only robotic radiotherapy system designed to treat tumors anywhere in the body with sub-millimetric accuracy. The CyberKnife System uses advanced image guidance technology to track and adjust for the patient's breathing and movement, allowing for precise radiation delivery to the tumor while sparing surrounding healthy tissue.

The company also offers the TomoTherapye System, a comprehensive radiation therapy system that combines precise treatment delivery with integrated CT imaging to effectively target tumors while minimizing exposure to healthy tissue. The TomoTherapy System is used for the treatment of a wide range of cancers, including prostate, breast, lung, head and neck, and brain tumors.

In addition, Accuray provides quality assurance and service management solutions for radiation therapy clinics through its AQUAe software platform. AQUA provides real-time monitoring and reporting of treatment machine performance and maintenance to ensure that treatments are delivered accurately and safely.

Accuray has a global footprint, with offices in the Americas, Europe, and Asia. The company has a strong focus on research and development, and invests heavily in advanced technologies to improve cancer treatment outcomes. Accuray's products and solutions have been used to treat over a million patients worldwide.

Overall, Accuray's precision radiation medicine solutions offer patients better treatment options, improved outcomes, and a higher quality of life. The company's dedication to innovation and patient-centered care has positioned it as a leader in the radiation therapy industry.


   Company Address: 1240 Deming Way Madison 53717 WI
   Company Phone Number: 824-2800   Stock Exchange / Ticker: NASDAQ ARAY


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EDAP        6.03% 
ISRG   -1.58%    
AMS   -2.72%    
GE   -1.59%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.08
Price to Sales (Expected) -
Price to Book 0.78
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.21
Working Capital Ratio 1.56
Leverage Ratio (MRQ) 9.64
Total Debt to Equity 3.58
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.4 $
Revenues (TTM) 3.27 $
Cash Flow (TTM) -
Cash 0.33 $
Book Value 0.34 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 495,467
Net Income per Employee (TTM) -60,808
Receivable Turnover Ratio (TTM) 5.95
Inventory Turnover Ratio (TTM) 1.93
Asset Turnover Ratio (TTM) 0.8

Profitability Ratios Current
Gross Margin (MRQ) 34.76 %
Operating Margin (MRQ) 5.47 %
Net Margin (MRQ) -1.92 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Accuray Incorporated's Segments
Product    171.14 % of total Revenue
Service    227.15 % of total Revenue
Americas    89.14 % of total Revenue
EIMEA    149.54 % of total Revenue
CN    67.52 % of total Revenue
JP    43.86 % of total Revenue
Asia Pacific    48.23 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.